Picture of Tonix Pharmaceuticals Holding logo

TNXP — Tonix Pharmaceuticals Holding News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Tonix Pharmaceuticals Holding Corp reports results for the quarter ended September 30 - Earnings Summary

* Tonix Pharmaceuticals Holding Corp  TNXP.OQ  reported a
quarterly adjusted loss of 23 cents​​ per share for the quarter
ended September 30, higher than the same quarter last year, when
the company reported EPS of $-58.56.  The mean expectation of
three analysts for the quarter was for a loss of $2.93 per
share. Wall Street expected results to range from $-7.36 to -40
cents per share.
    * Revenue fell 29.3% to $2.82 million from a year ago;
analysts
expected $3.08 million. 
    * Tonix Pharmaceuticals Holding Corp's reported EPS for the
quarter was a loss of 23 cents​.
    * The company reported a quarterly loss of $14.21 million.
    * Tonix Pharmaceuticals Holding Corp shares had fallen
by 5.5%
this quarter and lost 98.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 5.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Tonix
Pharmaceuticals Holding Corp is 11.00 
This summary was machine generated from LSEG data November 12 at
03:27 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -2.93          -0.23          Beat
 Jun. 30 2024      -3.27          -19.28         Missed
 Mar. 31 2024      -12.48         -5.76          Beat
 Dec. 31 2023      -52.59         -27.52         Beat

Recent news on Tonix Pharmaceuticals Holding

See all news